Patient-reported symptoms provide visibility into the day-to-day changes that may be missed during periodic clinic assessments. But collecting PRO data alone isn't enough. The value comes from turning those data into timely action.
Originally published in Cancer Control, this perspective from Bill Byrom, PhD, and Anthony Everhart, MD, explores how electronic patient-reported outcomes (ePRO) can support remote symptom monitoring and timely clinical intervention in oncology.
What you’ll learn
- Why clinician assessments may underestimate the frequency and severity of patient-reported symptoms
- How frequent ePRO monitoring can help identify worsening symptoms earlier
- How visualizations can surface symptom patterns and changes
- How predefined alert thresholds can prompt timely clinical follow-up
- What sponsors should consider when incorporating active symptom monitoring into oncology trial design
Publication and authors
Bill Byrom, PhD, Vice President, eCOA Science, Signant Health
Anthony Everhart, MD, Clinical Vice President, Internal Medicine, Signant Health
